These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7323610)

  • 1. Failure to measure plasma activated factor XIII during disseminated intravascular coagulation.
    Rodeghiero F; Morbin M; Barbui T
    Ric Clin Lab; 1981; 11(4):333-6. PubMed ID: 7323610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A contribution to the pathology of acquired plasma factor XIII deficiency.
    Ballerini G; Guerra S; Rodeghiero F; Castaman G
    Semin Thromb Hemost; 1985 Oct; 11(4):357-61. PubMed ID: 4071061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome].
    Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K
    Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case with SLE showing acquired low plasma F.XIII level followed by severe hematoma characteristic of F.XIII deficiency].
    Okubo S; Yamano M; Yasunaga K
    Rinsho Ketsueki; 1988 Sep; 29(9):1522-6. PubMed ID: 3216525
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
    Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
    Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.
    Naderi M; Tabibian S; Menegatti M; Kalantar E; Kazemi A; Zaker F; Dorgalaleh A
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):933-935. PubMed ID: 26836269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukaemia.
    Rodeghiero F; Barbui T; Battista R; Chisesi T; Rigoni G; Dini E
    Thromb Haemost; 1980 Feb; 43(1):6-9. PubMed ID: 6996205
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited.
    Ichinose A
    Semin Thromb Hemost; 2011 Jun; 37(4):382-8. PubMed ID: 21805444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factor XIII].
    Takahashi I; Fukue H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():660-2. PubMed ID: 15658417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.